DUBLIN, Oct. 20, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Proton Therapy Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation.
Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy.
The analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Proton Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various products used for the treatment of cancer using the proton beam therapy.
The report, Global Proton Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Proton Therapy market landscape and its growth prospects in the coming years in the Americas, and the EMEA and APAC regions. The report also includes a discussion of the key vendors operating in this market.
One major trend in the market is the rise in demand for proton therapy despite the high-cost structure leading to the implementation of more proton therapy centers, resulting in market growth.
According to the report, one of the main drivers in this market is the technological advances in medical diagnostics and therapeutics. The advances in technology led to the implementation of low-energy cyclotron centers for the irradiation procedure, which is the major part of proton therapy.
Further, the report states that one of the main challenges in the market is the high cost of proton therapy treatment. Despite numerous benefits, the high cost hinders acceptability among patients. Many patients do not have the required budget for investing in high-cost treatment options.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Significance of Proton Therapy
08. List of Proton Therapy Centers
09. Reimbursement Scenario
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challengess
15. Impact of Drivers and Challenges
16. Market Trendss
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
Companies Mentioned:
- Accuray
- Advanced Oncotherapy
- Advanced Particle Therapy
- Advanced Proton Solutions
- Best Particle Therapy
- Compact Particle Acceleration
- Elekta
- GE Healthcare
- Hitachi
- IBA Proton Therapy
- Mevion Medical Systems
- Mitsubishi Electric
- Optivus ProtonTherap
- ProNova Solutions
- ProTom International
- Procure Treatment Center
- SAH Global
- Siemens
- Sumitomo Heavy Industries
- Toshiba
- Varian Medical Systems
For more information visit http://www.researchandmarkets.com/research/pxlvhg/global_proton
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
